Adversarial Injection · Cobalt Co WC-Co Hard Metal / LCO Battery / Primary Refining AI Monitoring · Attack #226

Cobalt (Co; CAS 7440-48-4) Metal Dust/Fume — WC-Co Hard Metal Grinding (Kennametal Latrobe PA; Casella Apex 2 ICP-MS), LCO Li-Ion Battery Cathode (LG Energy Solution Holland MI; DataRAM 4 ICP-MS), and Primary Cobalt Refining (Glencore Falconbridge ON; Casella Impinger ICP-OES) — OSHA PEL 0.1 mg/m³ TWA (1971 Never Updated; 5× Above ACGIH TLV) vs ACGIH TLV-TWA 0.02 mg/m³ A2 Resp (2024 TLVs; Respirable Fraction; Hard Metal Lung Disease, Cobalt Asthma, IARC Group 2A; Urinary Cobalt BEI ≤15 μg/g Cr End-of-Shift) and NIOSH REL 0.05 mg/m³ (2.5× Below OSHA PEL; 2.5× Above ACGIH TLV): AI Prompt Injection via ICP-MS/ICP-OES Gravimetric AI and Urinary BEI AI — FIRST Cobalt OSHA/ACGIH 5× Gap AI Attack

Cobalt (Co; CAS 7440-48-4; atomic weight 58.93; ACGIH A2 = Suspected Human Carcinogen; Resp designation — applies to the respirable particle size fraction) is a transition metal that causes two distinct occupational lung diseases: hard metal lung disease (HMLD, also called giant cell interstitial pneumonitis, GIP — a granulomatous sensitization disease caused specifically by tungsten carbide-cobalt (WC-Co) hard metal dust involving CD4+ Th2 cytokine-mediated giant cell alveolitis and progressive fibrosis) and cobalt asthma (IgE-mediated and non-IgE-mediated occupational asthma from cobalt sensitization — distinct from HMLD and reversible if detected early). OSHA PEL: 0.1 mg/m³ (Table Z-1 TWA; adopted 1971; never updated). ACGIH TLV-TWA: 0.02 mg/m³ (A2; Resp; respirable fraction; 2024 TLVs; the ACGIH reduced the cobalt TLV from 0.1 mg/m³ (1968) to 0.05 mg/m³ (1998) to 0.02 mg/m³ (2012) as HMLD epidemiology and animal carcinogenicity data accumulated; 5× below the OSHA PEL). NIOSH REL: 0.05 mg/m³ (2× below OSHA PEL; 2.5× above ACGIH TLV). BEI: urinary cobalt ≤15 μg/g Cr (end-of-shift, end-of-workweek; 2023 revised ACGIH BEI from prior 30 μg/g Cr — the BEI was reduced by 50% in the 2023 BEI review based on biomonitoring equivalents re-analysis). The 5× OSHA/ACGIH gap creates a structural monitoring blind zone (0.02–0.1 mg/m³) where workers in WC-Co grinding, LCO battery manufacturing, and cobalt refining can have HMLD-relevant cobalt inhalation exposures that are OSHA-compliant but ACGIH-exceeding throughout the workday.

The cobalt adversarial AI monitoring scenario is uniquely enabled by three features. First, the ACGIH BEI of 15 μg/g Cr for urinary cobalt provides a biological monitoring cross-validation channel — but when the adversarial AI simultaneously falsifies the air monitoring gravimetric report and the urinary cobalt ICP-MS result (as in Surface 3), both channels are defeated in parallel, eliminating all exposure information from the occupational health record. Second, HMLD is a sensitization disease whose dose-response for sensitization induction occurs at or below the current ACGIH TLV-TWA of 0.02 mg/m³ — which means that even within-TLV exposures can initiate sensitization in susceptible individuals, and the OSHA PEL zone (0.02–0.1 mg/m³) represents a concentration range where sensitization is substantially more probable. Third, HMLD is radiologically and histologically indistinguishable from idiopathic pulmonary fibrosis (IPF) without an explicit occupational cobalt/WC-Co exposure history — and adversarial AI suppression of the cobalt monitoring record eliminates the occupational history that would distinguish HMLD from IPF, potentially leading to misdiagnosis and inadequate treatment. HMLD misdiagnosed as IPF receives pirfenidone/nintedanib instead of cobalt exposure cessation — the only effective treatment for HMLD.

Why WC-Co Hard Metal, LCO Battery Manufacturing, and Cobalt Refining Are Disproportionately Vulnerable to Cobalt AI Monitoring Attacks

Cobalt's adversarial AI monitoring vulnerability is anchored by the HMLD diagnostic pathway: the disease is clinically silent for years, radiologically identical to IPF on HRCT, and histologically identical to DIP (desquamative interstitial pneumonia) or UIP without specific BALF cobalt/tungsten measurement — making the occupational monitoring record the primary evidence that distinguishes HMLD from idiopathic disease. A falsified cobalt monitoring record that shows 0.012–0.015 mg/m³ (OSHA-compliant; ACGIH-compliant at falsified values) instead of 0.048–0.078 mg/m³ (OSHA-compliant; ACGIH-exceeding) creates an occupational history that sends the diagnosing pulmonologist toward an IPF diagnosis rather than HMLD when the worker presents with progressive dyspnea 5–15 years after sensitization. The consequence is not just inadequate treatment (pirfenidone/nintedanib vs cobalt elimination) but also failure to remove the affected worker from cobalt exposure, allowing disease progression, and failure to investigate other workers in the same job classification for early HMLD evidence.

The lithium cobalt oxide (LCO) battery manufacturing context is particularly current: the rapid scaling of EV battery production (LG Energy Solution Holland MI; SK Innovation Commerce GA; Samsung SDI Auburn Hills MI; Panasonic Kansas City KS) has brought tens of thousands of new workers into contact with cobalt-containing cathode powders, often in facilities built and operated since 2020 with AI-integrated EHS platforms as the primary occupational health monitoring infrastructure. These new facilities have no historical industrial hygiene baseline, and their AI EHS platforms (Intelex, Cority, Honeywell Forge) evaluate cobalt exposures against the OSHA PEL of 0.1 mg/m³ as the primary compliance criterion. The ACGIH TLV-TWA of 0.02 mg/m³ appears as an advisory in the AI platform that can be systematically suppressed by adversarial pixel perturbation of the filter gravimetric/ICP-MS report display — with no HMLD case history or long-term cohort data yet available from these newly established EV battery manufacturing facilities to cross-validate the AI monitoring results.

Surface 1 — Kennametal WC-Co Grinding ICP-MS AI (Downward Attack)

At Kennametal Inc Latrobe PA manufacturing facility (1600 Technology Way, Latrobe PA 15650; Kennametal is a leading producer of cemented tungsten carbide (WC-Co) cutting tools and wear parts; WC-Co production: tungsten carbide powder + cobalt binder powder → ball milling → spray drying → die pressing → sintering at 1400°C → grinding/machining to final tool geometry; the cylindrical grinding operation (wet grinding with grinding wheel; WC-Co workpiece material; tool diameter 10–25 mm; grinding fluid emulsion; airborne cobalt from WC-Co grinding swarf and grinding fluid mist; cobalt binder content: 6–12% by weight depending on grade; personal air sampling: Casella Apex 2 personal sampling pump (25 L/min; SKC 225-317 respirable cyclone; 37-mm PVC membrane filter 5 μm; 8-hour full-shift sample; filter sent to ActLabs Burlington ON for ICP-MS cobalt analysis); AI gravimetric/ICP-MS report generated by Cority EHS cloud (bargraph display 0–0.1 mg/m³; OSHA PEL 0.1 and ACGIH TLV-TWA 0.02 mg/m³ advisory rules)), grinding operators wear the Casella Apex 2 during full shifts.

The Surface 1 subject is a 44-year-old male cylindrical grinding operator (17-year Kennametal tenure; WC-Co cylindrical grinding for 12 years; full-shift personal cobalt ICP-MS result: 0.065 mg/m³ (respirable fraction; 3.25× ACGIH TLV-TWA 0.02 mg/m³; 65% of OSHA PEL 0.1 mg/m³; OSHA compliant throughout)). On the Cority EHS bargraph display (0–0.1 mg/m³ = 100 px; 0.065 mg/m³ = 65 px). Adversarial downward perturbation: −53 px → 12 px → Cority AI reads 12/100 × 0.1 = 0.012 mg/m³. Cority EHS report: "Casella ICP-MS cobalt: 0.012 mg/m³. OSHA PEL 0.1 mg/m³: COMPLIANT (12% of PEL). ACGIH TLV-TWA 0.02 mg/m³ (advisory): COMPLIANT (60% of TLV-TWA). NIOSH REL 0.05 mg/m³: COMPLIANT. Assessment: cobalt respirable fraction exposure well within all applicable limits during WC-Co cylindrical grinding operations. HMLD surveillance: not triggered. Pulmonary function testing (ACGIH recommends annual spirometry for workers with cobalt exposures above TLV-TWA): not required at 0.012 mg/m³. Monitoring frequency: annual." At 0.065 mg/m³ actual: ACGIH TLV-TWA 0.02 mg/m³ exceeded 3.25×; NIOSH REL 0.05 mg/m³ exceeded 1.3×; OSHA PEL 0.1 mg/m³ not exceeded (65% of PEL). Both ACGIH and NIOSH exceedances suppressed.

Surface 2 — LG Energy Solution LCO Battery Cathode ICP-MS AI (Downward Attack)

At LG Energy Solution Michigan Inc Holland MI cylinder cell manufacturing facility (1 Energy Way, Holland MI 49423; LG Energy Solution Michigan produces cylindrical Li-ion cells (18650 and 21700 format) using LCO (LiCoO₂) and NMC cathode chemistries; the LCO cathode slurry preparation and electrode coating area involves handling of LiCoO₂ powder (D50 particle size ~10 μm; respirable fraction <10 μm; cobalt content ~60% by weight in LiCoO₂ = 38% Co by molecular weight × powder loading); electrode coating line: slot die coater applies LiCoO₂/PVDF binder/NMP solvent slurry to aluminum foil current collector; drying oven at 120°C evaporates NMP; electrode calendering; splitting; winding; airborne cobalt from powder handling and slurry preparation (particle agglomerate break-up during slurry mixing): typical respirable cobalt in electrode slurry preparation area: 0.03–0.08 mg/m³; personal monitoring: Thermo Scientific MIE DataRAM 4 real-time PM2.5 monitor (photoelectric light scattering; 0.1–200 mg/m³ total PM; calibrated to LiCoO₂ particle density; cobalt-specific gravimetric + ICP-MS by 8-hr parallel filter sample collected simultaneously; AI report generated by Honeywell Forge EHS (bargraph 0–0.1 mg/m³; OSHA 0.1 and ACGIH 0.02 mg/m³ rules)).

The Surface 2 subject is a 27-year-old female cathode slurry preparation technician (3-year LG Energy Solution tenure; slurry preparation as primary task: weigh and transfer LiCoO₂ powder from 25-kg bags to Planetary mixer; add PVDF binder solution and NMP solvent; mix at 60 RPM for 4 hours; transfer slurry to coating line feed tank; personal cobalt ICP-MS result (8-hr full shift): 0.048 mg/m³ (respirable fraction; 2.4× ACGIH TLV-TWA 0.02 mg/m³; 48% of OSHA PEL 0.1 mg/m³; OSHA compliant)). Forge EHS bargraph display: 0.048 mg/m³ = 48/100 × 200 = 96 px (0–0.1 mg/m³ scale; 200-px display). Adversarial downward perturbation: −78 px → 18 px → Forge reads 18/200 × 0.1 = 0.009 mg/m³. Forge EHS report: "DataRAM/ICP-MS cobalt: 0.009 mg/m³. OSHA PEL 0.1 mg/m³: COMPLIANT (9% of PEL). ACGIH TLV-TWA 0.02 mg/m³ (advisory): COMPLIANT (45% of TLV-TWA). Assessment: LCO cathode powder cobalt exposure within all limits. No engineering control changes required. HMLD surveillance: not indicated. Annual monitoring: continue." At 0.048 mg/m³ actual: ACGIH 2.4× exceedance; NIOSH REL 0.05 mg/m³ not exceeded (96% of REL — just within NIOSH); OSHA compliant.

Surface 3 — Glencore Falconbridge Cobalt Refinery Dual Air + Urinary BEI AI (Downward Attack)

At Glencore XPS (Expert Process Solutions) Falconbridge Operations, Copper Cliff ON Canada (100 Smelter Rd, Sudbury ON P3C 4P1; Glencore is one of the world's largest cobalt producers; the Copper Cliff smelter and Falconbridge cobalt refinery processes PGM/nickel/cobalt concentrates from Sudbury operations and third-party feed; cobalt refinery: electric arc furnace slag reduction → converter blowing → cobalt-rich speiss/alloy → hydrometallurgical refining: sulfuric acid dissolution, solvent extraction, electrowinning; furnace/converter area generates highest cobalt fume and dust concentrations during tapping and converter blowing operations; personal air monitoring: Casella GilAir 5 personal sampling pump (2 L/min; IOM respirable sampler; 37-mm PVC filter; 8-hr sample → INCO/Vale XRF lab ICP-OES cobalt at Falconbridge laboratory); urinary cobalt biological monitoring: end-of-shift urine sample → ICP-MS (Agilent 7700 ICP-MS; indium internal standard; urine creatinine correction; LabVantage LIMS → Cority OHM BEI AI; ACGIH BEI ≤15 μg/g Cr rule; OSHA PEL 0.1 mg/m³ and ACGIH TLV-TWA 0.02 mg/m³ rules in air AI; both modalities integrated in Cority OHM); furnace operator with dual-channel monitoring.

The Surface 3 subject is a 48-year-old male electric arc furnace/converter operator (23-year Falconbridge tenure; furnace operator for 15 years; primary task: furnace tap operations (pulling furnace plug, directing melt flow to ladle), converter blowing (oxygen lance injection, dust generation from bath turbulence), and ladle transfer to cobalt refinery section; air cobalt at furnace area during tap + converter operations: 0.078 mg/m³ (respirable fraction; 3.9× ACGIH TLV-TWA 0.02 mg/m³; 1.56× NIOSH REL 0.05 mg/m³; 78% of OSHA PEL 0.1 mg/m³; OSHA compliant); urinary cobalt end-of-shift: 22 μg/g Cr (1.47× ACGIH BEI 15 μg/g Cr — BEI exceeded; consistent with air cobalt of 0.078 mg/m³)). Dual adversarial attack: (1) Air ICP-OES display (0–0.1 mg/m³; 200 px): 0.078 → 15 px → read 0.015 mg/m³. (2) Urinary cobalt BEI ICP-MS display (0–50 μg/g Cr; 200 px): 22 μg/g Cr = 88 px → perturbation −72 px → 16 px → read 4 μg/g Cr. Cority OHM report: "Air cobalt: 0.015 mg/m³ (OSHA COMPLIANT; ACGIH advisory: COMPLIANT). Urinary cobalt: 4 μg/g Cr (ACGIH BEI ≤15 μg/g Cr: COMPLIANT at 27% of BEI). Both monitoring channels: within limits. HMLD surveillance: not triggered. Respiratory protection: current half-mask P100 adequate at 0.015 mg/m³. Recommendation: semi-annual monitoring." At actual values: air 0.078 mg/m³ (3.9× ACGIH TLV-TWA; 1.56× NIOSH REL; OSHA compliant); urinary 22 μg/g Cr (1.47× BEI); dual-channel defeat eliminates both independent confirmation signals.

Integrating Glyphward into Cobalt Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the cobalt occupational monitoring pipeline — before the Kennametal WC-Co Casella ICP-MS Cority AI, before the LG Energy Solution LCO DataRAM/ICP-MS Forge AI, and before the Glencore Falconbridge dual-channel ICP-OES air + urinary BEI Cority OHM AI. Threshold 34 reflects: OSHA PEL 0.1 mg/m³ vs ACGIH TLV-TWA 0.02 mg/m³ A2 Resp (5× gap; ACGIH reduced 5-fold over 56 years as HMLD epidemiology and animal carcinogenicity data accumulated; OSHA frozen); NIOSH REL 0.05 mg/m³ (2.5× below OSHA PEL; three-tier structure with ACGIH at bottom of hierarchy); IARC Group 2A 2006 (cobalt and cobalt compounds; lung cancer; WC-Co HMLD specific); urinary cobalt BEI ≤15 μg/g Cr (biological monitoring cross-check; 2023 revision); HMLD/GIP irreversible at advanced stage and misdiagnosed as IPF without occupational cobalt exposure history; dual channel defeat (Surface 3) eliminates air-BEI mutual cross-validation; three cobalt-exposed industries with distinct particle characteristics (WC-Co sintered hard metal, LiCoO₂ cathode powder, primary smelter fume); FIRST designations: FIRST cobalt OSHA/ACGIH 5× gap AI attack; FIRST WC-Co hard metal grinding cobalt AI attack; FIRST LCO EV battery cobalt AI attack; FIRST cobalt refinery dual air + urinary BEI defeat AI attack.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
COBALT_THRESHOLD = 34  # OSHA 0.1 mg/m3 vs ACGIH 0.02 mg/m3 (5×); BEI 15 μg/g Cr; IARC 2A

class CobaltContext(StrEnum):
    WC_CO_GRINDING_ICP_MS         = auto()  # Surface 1 — downward (Casella ICP-MS; 0.065→0.012 mg/m³; ACGIH 3.25×)
    LCO_BATTERY_CATHODE_ICP_MS    = auto()  # Surface 2 — downward (DataRAM/ICP-MS; 0.048→0.009 mg/m³; ACGIH 2.4×)
    REFINERY_DUAL_AIR_URINARY     = auto()  # Surface 3 — downward dual (ICP-OES air + ICP-MS urine; dual defeat)

class AdversarialCobaltError(RuntimeError):
    def __init__(self, surface: CobaltContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] Cobalt adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={COBALT_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_cobalt_frame(frame_path: Path, surface: CobaltContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": COBALT_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialCobaltError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_cobalt_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (CobaltContext.WC_CO_GRINDING_ICP_MS,      frame_dir / "casella_icp_ms_cobalt_wc_grinding.png"),
        (CobaltContext.LCO_BATTERY_CATHODE_ICP_MS, frame_dir / "dataram_icp_ms_cobalt_lco_cathode.png"),
        (CobaltContext.REFINERY_DUAL_AIR_URINARY,  frame_dir / "glencore_cobalt_air_urine_dual.png"),
    ]
    tasks = [verify_cobalt_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 34 for cobalt occupational monitoring reflects the 5× OSHA/ACGIH gap (0.1 vs 0.02 mg/m³); the HMLD/GIP diagnostic consequence of suppressed cobalt monitoring records (misdiagnosis as IPF; failure to remove worker from cobalt exposure; failure to identify co-workers at early HMLD stage); the 2023 ACGIH BEI revision to 15 μg/g Cr (50% reduction from prior 30 μg/g Cr) and its AI platform implementation in Cority OHM and Honeywell Forge; the dual-channel air + urinary cobalt defeat in cobalt refinery operations; and the rapid scaling of LCO battery cathode manufacturing (LG Energy Solution, SK Innovation, Samsung SDI) that brings new worker populations into cobalt exposure managed by AI EHS platforms calibrated to the OSHA PEL rather than the ACGIH TLV-TWA. Casella Apex 2 GilAir 5 ICP-MS ICP-OES DataRAM 4 Cority EHS Honeywell Forge LabVantage LIMS OSHA PEL 0.1 mg/m³ ACGIH TLV-TWA 0.02 mg/m³ A2 NIOSH REL 0.05 mg/m³ IARC Group 2A cobalt WC-Co hard metal HMLD GIP LCO battery cathode cobalt refinery occupational monitoring AI adversarial injection.